Apogee Therapeutics, LLC

The biopharmaceutical industry has been through a tremendous period of company creation, and even with a drop in financings during 2022 and 2023 from record levels of funding in 2020 and 2021, the las

Rising Leaders Home Waltham, MA-based Apogee Therapeutics, LLC launched at the end of 2022 as a spin-out from Paragon Therapeutics, with $169m funding and a handful of inflammation and immunology (

Viking Therapeutics ’ share price soared in Q1 as generalist investors continued their landgrab of biopharma companies developing novel obesity therapies. That put it top of the share price gainers am

Included for 2024 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, as well as individuals driving unique health initiatives worldwide. The 30 people below h